Skip to content
10-Q

Quarterly Report

BIOCLINICA INC

0001104659-11-063886

← back to feed
Filed
Nov 14, 2011 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2011 · Oct 31, 2011 15.66M sh
Stockholders Equity Q3 2011 · Sep 30, 2011 $56.93M
Stockholders Equity Q3 2011 · Dec 31, 2010 $54.88M
Current Liabilities Q3 2011 · Sep 30, 2011 $22.07M
Current Liabilities Q3 2011 · Dec 31, 2010 $19.83M
Total Liabilities Q3 2011 · Sep 30, 2011 $28.1M
Total Liabilities Q3 2011 · Dec 31, 2010 $25.15M
Current Assets Q3 2011 · Sep 30, 2011 $32.47M
Current Assets Q3 2011 · Dec 31, 2010 $28.44M
Total Assets Q3 2011 · Sep 30, 2011 $85.03M
Total Assets Q3 2011 · Dec 31, 2010 $80.03M
Shares Diluted Q3 2011 · Sep 30, 2010 15.8M sh
Shares Diluted Q3 2011 · Sep 30, 2010 15.73M sh
Capex Q3 2011 · Sep 30, 2010 $2.3M
Operating Cash Flow Q3 2011 · Sep 30, 2010 $3.07M
Cash And Equivalents Q3 2011 · Sep 30, 2010 $11.82M
Cash And Equivalents Q3 2011 · Dec 31, 2009 $14.57M
Eps Diluted Q3 2011 · Sep 30, 2010 $0.05
Eps Diluted Q3 2011 · Sep 30, 2010 $0.12
Eps Basic Q3 2011 · Sep 30, 2010 $0.05
Eps Basic Q3 2011 · Sep 30, 2010 $0.13
Sga Expense Q3 2011 · Sep 30, 2010 $2.07M
Sga Expense Q3 2011 · Sep 30, 2010 $6.06M
Net Income Q3 2011 · Sep 30, 2010 $808K
Net Income Q3 2011 · Sep 30, 2010 $1.92M
Operating Income Q3 2011 · Sep 30, 2010 $1.29M
Operating Income Q3 2011 · Sep 30, 2010 $3.11M
Revenue Q3 2011 · Sep 30, 2010 $18.32M
Revenue Q3 2011 · Sep 30, 2010 $55.66M